Early dose adjustment of RBV in HCV patients treated with peginterferon and RBV is efficient and safe in the population underexposed to the drug. Multicentric French Study (Ribajuste)
HEPATOLOGY（2015）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要